Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
High throughput thin film characterization and defect detection
System and method for locating, tracking, and/or monitoring the status of personnel and/or assets both indoors and outdoors
Adjustable voltage regulator with dynamic voltage compensation
Methods and systems for detecting icing conditions
Methods and apparatuses for configuring and operating graphics processing units
Contactless electrical connector for an induction sensor, and sensor including such a connector
Semiconductor device and manufacturing method thereof
  Randomly Featured Patents
Tool-shaft locking device for a planing machine
Chip package with die and substrate
Electric driving device
Distributed telecommunications switching system
Methods and apparatus for facilitating security and tamper control
Method and apparatus for remotely and releasably sealing a pipeline
Hydro-mechanical valve actuation system for split-cycle engine
Quick change work station apparatus for automatic wire bonders
Wound exudate removal and isolation system
Lightweight ceramic material for building purposes, process for the production thereof and the use thereof